Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Agensys submits IND for phase I study of AGS-PSCA

July 5, 2005

Phase I trial studies huC242-DM4 for cancer

June 29, 2005

Enrollment completed in phase III PROTECT study of Provenge

June 27, 2005

WT1-peptide vaccination proven effective in acute myeloid leukemia

June 27, 2005

ImClone to file sBLA for Erbitux in head and neck cancer in Q3

June 23, 2005

Galiximab increases the antitumor efficacy of rituximab in follicular lymphoma

June 20, 2005

Avantogen receives milestone payment from Endocyte

June 20, 2005

Kuhnil expands development of nimotuzumab to Korea

June 17, 2005

FDA agrees to rolling NDA for Virulizin

June 15, 2005

Phase I study for Tarvacin in refractory advanced solid tumors

June 15, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...